Oxycodone hydrochloride 10 mg and 20 mg: Supply issue

Supply issue Active

The supplier of oxycodone hydrochloride controlled-release tablets has advised that they are experiencing supply constraints impacting the 10 mg and 20 mg strengths.

Sandoz has advised that Oxycodone Sandoz S29:

  • 10 mg (30-pack) is available for supply
  • 10 mg (50-pack) is available for supply
  • 20 mg (50-pack) is available for supply.

We are working with the supplier to understand re-supply timeframes.  

Affected products:

Tab controlled-release 10 mg | Oxycodone Sandoz  | 2559722 | $2.15 per 20(external link)

Tab controlled-release 20 mg | Oxycodone Sandoz  | 2559730 | $2.15 per 20(external link)

Alternative products listed

We have listed Sandoz's alternative products to ensure continuity of supply. These are available in a variety of pack sizes that are listed on the Pharmaceutical Schedule.

Check the Schedule listing for oxycodone(external link)

These alternative products are not Medsafe approved, as such they need to be supplied under section 29 of the Medicines Act.

Supplying a medicine under section 29

Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – eg doctors. 

We know supplying a medicine under section 29 is not ideal. In this case, however, the alternative would be for patients to have no oxycodone in these strengths. 

We apologise for any inconvenience this causes. 

Read more about supplying medicines under section 29 – Medsafe website(external link)

Information for people taking medicine about what section 29 means – Health Navigator website(external link)

Who to contact

If you have any questions about this supply issue, please contact Sandoz:

If you have any questions about funding of these medicines, contact enquiry@pharmac.govt.nz